L63 encodes a CDK-like protein homologous to the mammalian PFTAIRE. We showed previously that L63 provides a CDK-related function critical to development (Dev. Biol. 221 (2000) 23). We present here the first biochemical characterization of L63 kinase. In addition, we describe two novel Drosophila proteins, PIF-1 and PIF-2 (for PFTAIRE Interacting Factor-1 and -2), identified in a two-hybrid screen for their ability to interact with the amino-terminal region of L63. The full-length PIF-1 cDNA shows an unusual dicistronic organization. PIF-1A and PIF-1B (the L63 interactor) predicted proteins are expressed in vivo, and show a distinct expression profile during development. Interaction between L63 and PIF-1B was confirmed in vitro and in vivo. The role of this interaction remains to be demonstrated, but our data suggest that PIF-1B might serve as a regulator of L63. q
Introduction
The Drosophila L63 gene is required maternally and for the embryonic, larval and metamorphic stages of development (Stowers, 1997; Stowers et al., 2000) . It contains two overlapping transcription units of , 85 (L63A) and , 60 kb (L63B) that have a common 3 0 end and encode, respectively, two (L63A1,2) and three (L63B1,2,3) protein isoforms (Fig.  1 ). Whereas L63A is active throughout development, L63B activity is largely limited to late embryogenesis and the latelarval to early-pupal phases of metamorphosis, in keeping with its regulation by the steroid hormone 20-hydroxyecdysone (Stowers et al., 2000) . A striking characteristic of the five L63 isoforms is how little they differ from one another. Each isoform consists of a cyclin-dependent kinase (CDK) domain with long N-terminal and short C-terminal extensions ( Fig. 1) . Variation among the isoforms in their primary structure occurs only in their N-terminal extensions and is the result of a different choice among exons encoding the Nterminal residues and alternative splicing events (Stowers et al., 2000) . Thus, the 522 aa sequence of the A1 and B1 isoforms differ only in respect to their 19 N-terminal residues; the A2 and B2 isoforms differ from the A1 and B1 isoforms, respectively, only by the absence of 13 residues; and all 501 aa of the B3 isoform are encoded by the common exons (Fig. 1) .
The structural similarity among the five L63 isoforms suggests that they may be functionally equivalent, and indeed this appears to be the case, at least in part. Thus Stowers et al. (2000) showed: (i) that L63 null mutant embryos can be rescued to adulthood by the periodic and ubiquitous ectopic expression of a single L63 isoform, B1; and (ii) that the A1 and A2 isoforms are not required for any stage of the Drosophila life cycle when the B isoforms are present. Furthermore, the tissue and cellular distribution of the L63 proteins during development indicate that their developmental functions do not include cell-cycle regulation (Stowers et al., 2000) . The anatomical and temporal analysis of the effects of L63 mutations on Drosophila development have demonstrated that L63 proteins are required not only for all developmental stages but also for the morphogenesis of a wide variety of tissues. Thus phenotypical analysis of rare mutant survivors indicates L63 protein involvement in the regulation of organism size and in epithelial morphogenesis during development of adult appendages from imaginal discs (Stowers et al., 2000) .
Initially defined by the sequence similarity to the yeast cyclin-dependent kinase, CDC28, the L63 CDK domain present in each isoform ( Fig. 1 ) exhibits comparable sequence similarities to the structurally and catalytically defined human CDK2 and CDK5 proteins (Table 1) . Whereas CDK2 is activated by cyclins for the cell-cycle control (Nigg, 1995; Pavletich, 1999) , CDK5 is activated by proteins such as p35, and its p25 derivative, that play a critical role in the development of the postmitotic neurons and exhibit little or no sequence similarity to the cyclins (Lew et al., 1994; Tarricone et al., 2001; Tsai et al., 1994) . Given that the L63 proteins also appear to be devoid of cellcycle functions (Stowers et al., 2000) , one might suppose that their activation mechanism is more like that of CDK5 than CDK2. This, however, does not appear to be the case. CDK2 activation is a two-step process consisting of cyclin binding followed by phosphorylation of a specific threonine residue (T160) by a CDK activating kinase (Pavletich, 1999) . Two critical alterations of CDK2 structure result from cyclin A binding: (i) a change in the position of the PSTAIRE helix (named for its amino acid sequence) so that its highly conserved terminal glutamate residue (E51) is inserted into a catalytic cleft where it plays a crucial role in correctly orienting the ATP phosphate atoms for catalysis; and (ii) a change in configuration of a regulatory loop (T loop) that provides access to the catalytic cleft and exposes its T160 residue for phosphorylation. This phosphorylation is critical, resulting in a 100-fold increases in kinase activity (Pavletich, 1999) . By contrast, the interaction between CDK5 and p25 leads directly, without phosphorylation, to a conformation in which the CDK5 PSTAIRE helix (PSSALRE in CDK5) and its T-loop mimics that of the active phosphorylated CDK2 (Tarricone et al., 2001) . Accordingly, substitution of alanine for the CDK5 serine S159, which corresponds to the phorsphorylated T160 of CDK2, does not affect either the formation or activity of the CDK5/p35 complex, (Tarricone et al., 2001) . Stowers et al. (2000) adapted the previously noted technique of rescuing L63 null embryos to adulthood by expression of the L63B1 isoform to test the effect of single amino acid substitutions on this rescue activity. One of these substitutions mimicked the S159A mutation of CDK5, at position S359 of L63B1. This S359A mutant protein failed to rescue the L63 null embryos. This is opposite to the result obtained with CDK5 and consistent with a requirement for S359 phosphorylation, as is the case for T160 in CDK2.
While these results indicate that the activation mechanism for L63 kinase activity is more like that for human CDK2 than human CDK5, the overall sequence similarity between CDK2 and the CDK-domain of the Drosophila L63 isoforms is relatively weak compared to that for true homologues (Table 1) . The best candidate for the true mammalian homologues of the L63 proteins are the mouse and human PFTAIRE proteins, which take their names from the amino acid sequence of the region corresponding to the PSTAIRE helix noted above for the human CDK2 (Besset et al., 1998; Lazzaro et al., 1997) . This PFTAIRE sequence is also present in the presumptive helical region of the L63 isoforms, and indeed, was once used to name the L63A2 isoform, as defined by a single cDNA sequence (Sauer et al., 1996) . The sequence similarity between these mammalian PFTAIRE proteins and the L63 isoforms extends throughout their CDK domains, both exhibiting 70% sequence identity to that of L63 (Table 1) . The probability that these mammalian PFTAIRE proteins are true homologues of the L63 proteins is enhanced by the fact that they too exhibit quite long N-terminal extensions that, at 82 and 110 residues for the mouse and human respectively, are about half the length of the L63 extensions (Fig. 1) . Similarly, they exhibit Fig. 1 . Structure of L63 proteins. The CDK domain and the short C-terminal extension are common to all five isoforms. The 522 amino acid (aa) sequence of the A1 and B1 isoforms differ only in respect to their 19 Nterminal residues. The A2 and B2 isoforms differ from the A1 and B1 isoforms respectively, only by the absence of 13 residues encoded by the third of the ten common exons. All 501 aa of the B3 isoform are encoded by the common exons. Amino acids 19 -522 of L63B1 were used as bait for the two-hybrid screen. HuCDK2  50  67  -HuCDK5  53  57  60  -HuPFTAIRE  70  50  52  53  -HuPCTAIRE-1 62  53  55  57  62  HuPITSLRE-a1 4 1  4 2  4 5  4 2  4 2  DmCDK1  47  74  64  57  47  DmCDK2  48  59  66  51  48  DmCDK5  51  55  57  79  50 a Note: Percentage amino acid identity calculated for CDK domains only.
short C-terminal extensions which show some sequence similarity with the proximal part of the short L63 C-terminal extension. However, no significant sequence similarities exist within the long N-terminal extension of Drosophila and mice. They are thus conserved by their presence but not their sequence. In addition, the kinase domain of L63 and PFTAIRE exhibit significant sequence identity to the mammalian PCTAIRE-1, -2 and -3 (Meyerson et al., 1992; Okuda et al., 1992) which, like PITLSRE (Lahti et al., 1995a,b) , belong to a family of CDK-like proteins characterized by N-and C-terminal variable extensions (Table 1 ).
In this paper we describe the results of a two-hybrid screen carried out in yeast to identify proteins that interact with L63 and may therefore act as regulators or substrates of the putative kinase. We identified two L63 interactors, PIF-1B and PIF-2 (PIF for PFTAIRE Interacting Factor). PIF-1B and PIF-2 are novel cysteine-rich proteins, both of which interact with the same domain within the non-conserved amino-terminal region of L63. The sequence of the fulllength PIF-1 cDNA revealed an unusual dicistronic organization, encoding for two putative proteins: PIF-1A and PIF-1B, of which only PIF-1B interacts with L63. Antibodies specific to PIF-1A and PIF-1B were generated and used to show that both proteins exhibit a broad but differential expression pattern during development. Interaction between L63 and PIF-1B was confirmed in vitro and in vivo. We also demonstrate for the first time that L63 is a functional protein kinase.
Results

Two Drosophila genes encode proteins that interact with the L63B1 isoform
The yeast two-hybrid system was used to screen Drosophila cDNA libraries for genes that encode proteins that can interact with the L63 protein isoforms. A full-length L63B1 cDNA (Fig. 1 ) was used to produce the 'bait' protein, while the peptides tested for interaction were encoded by two libraries of cloned cDNAs: a late third instar larval library, and a 34-54 h pupal library (Section 4). The B1 isoform was chosen as bait from among the five L63 isoforms (Fig. 1 ) not only because it contains all residues encoded by the ten common exons, but also because it is sufficient for Drosophila development in the absence of all other isoforms (Stowers et al., 2000) . Two distinct cDNAs were identified which encode peptides that interact with L63B1, but not with the three well-characterized Drosophila cyclin-dependent kinases: CDK1 (Cdc2), CDK2 (Cdc2c), and CDK5 (not shown; Section 4). The genes represented by these two cDNAs were named PIF-1 and PIF-2, where PIF stands for PFTAIRE Interacting Factor. The initial PIF-1 cDNA, at 1400 bp, was much smaller than the 7 kb mRNA it detected in Northern blots (Fig. 6) , prompting a search for a full-length cDNA clone. This was obtained from an embryonic cDNA library and yielded a 6356 bp PIF-1 cDNA. By contrast, the initial PIF-2 cDNA, at 864 bp, was almost complete. The 920 bp sequence of a full-length PIF-2 cDNA was deduced from a combination of the initial cDNA sequence, which is complete at the 3 0 end, and that of an EST from an adult testis library (accession AI947165), which is complete at the 5 0 end. GenBank accession numbers for the complete PIF-1 and PIF-2 cDNA sequences are AF273707 and AF273708, respectively. Fig. 2 shows the molecular maps of the PIF-1 and PIF-2 genes and their mRNAs as determined by comparison of their cDNA sequences to the corresponding genomic sequence (accession numbers AE003680 and AE003674 for PIF-1 and PIF-2, respectively). The PIF-2 gene is small and simple. It consists of two exons spanning 938 bp of genomic DNA and its 118 codons are all located within the second and largest exon. Although in situ hybridization of a PIF-2 cDNA probe (864 bp) to polytene chromosomes did Fig. 2 . Structure of PIF-1 and PIF-2 genes and coding regions. PIF-1 dicistronic mRNA is encoded by 12 exons (black boxes, numbered 1-12) spanning over 18 261 bp of genomic DNA (upper panel). Start and stop codons for PIF-1A and PIF-1B are indicated within the genomic DNA and the corresponding mRNA. The sequence at the PIF-1A/PIF-1B junction within the dicistronic mRNA is shown. The hatched box represents the yeast two-hybrid clone. The PIF-2 gene spans over 938 bp of genomic DNA, and contains two exons (black boxes) and one short intron (lower panel). Start and stop codons within exon 2 are indicated. GenBank accession numbers for PIF-1 and PIF-2 cDNA nucleotide sequences are AF273707 and AF273708 respectively. It should be noted that an EST database search revealed the existence of a monocistronic ,4 kb PIF-1B mRNA variant (PIF-1Bvar) containing an extra exon upstream of exon 9 at about 14 kb on the genomic map (accession BF496516), adding 165 aa residues at the N-terminus of PIF-1B. This unit may be responsible for the 4.0 kb band of RNA detected in the developmental Northern shown in Fig.  6A . A monocistronic mRNA variant for PIF-1A was also identified (accession AY119473). This protein (PIF-1Avar) consists of the 363 aa encoded by exons 7 and 8 plus 433 aa encoded by the sequence immediately downstream of exon 8.
not elicit an adequate signal, its DNA sequence places it at 83F3 -4, i.e. in the centromere-proximal quarter of 3R, the right arm of chromosome 3. In contrast, the PIF-1 gene is large and complex (Fig. 2) . This complexity derives not only from its 18 kb length and its 12 exons, but most strikingly, from the dicistronic structure of the PIF-1 mRNA. Thus, this mRNA contains two open reading frames (ORFs) in tandem such that the TGA stop codon for the first ORF (PIF-1A) overlaps the ATG initiation codon for the second ORF (PIF-1B) by the common A (Fig.  2) . PIF-1B encodes the protein that interacts with L63B1, as indicated in Fig. 2 by the 3 0 -terminal hatched region that represents the sequence of the partial PIF-1 cDNA identified in the two-hybrid screen. This identification was confirmed by using a full-length PIF-1B cDNA in the twohybrid assay (not shown). The PIF-1A protein does not interact with L63B1 in this two-hybrid assay (not shown). The amino acid sequences of the PIF-1A, PIF-1B and PIF-2 proteins are given in Fig. 3 . By contrast to PIF-1A, no conserved domains were identified within PIF-1B and PIF-2, although both contain cysteine-rich regions (see legend to Fig. 3 and text below).
PIF-1B and PIF-2 interact with the same histidine-rich domain present in the N-terminal extension of all L63 isoforms
Fig . 4A shows the results obtained from deletion mapping of L63B1 for domains that interact with PIF-1B or PIF-2 in a yeast two-hybrid assay that employed the PIF-1B (1400 bp) and PIF-2 (864 bp) cloned cDNAs. PIF-1B and PIF-2 peptides both interact with a site in a region bounded by residues 54 and 89 of L63B1. This region is located in the N-terminal extension and is present in all five L63 isoforms (Fig. 1 ). It exhibits a striking primary structure in which 13 of its 36 residues are histidines, of which 9 form a polyhistidine tract (Fig. 4B) . A similar region of unknown function is present in the ySNF1 protein kinase of Saccharomyces cerevisiae ( Fig. 4B ; Estruch et al., 1992) . As we have shown that both PIF-1B and PIF-2 interact strongly with ySNF1 in a two hybrid assay (data not shown; Section 4), the sequence [H] 9 XXGHGG present in both L63 and ySNF1 proteins appears to be sufficient for interaction with both PIF-1B and PIF-2. (3)CGP gene family and the mammalian ultra-high-sulfur keratin proteins. PIF-1A coding sequence contains putative leucinezipper motifs (blue, underlined) and coiled-coil domains (yellow boxes). No known conserved motifs were found within PIF-1B and PIF-2. However, both amino acid sequences contains cysteine-rich regions (red). The interaction domains with L63 identified in the yeast two-hybrid assay (Fig. 5 ) are highlighted in light green within PIF-1B (residues 788-815) and PIF-2 (residues 9-64). The two-hybrid clone starts at codon 683 of PIF-1B (indicated in dark green).
L63B1 interacts with cysteine-rich domains in PIF-1B and PIF-2
Fig . 5A shows the results of deletion mapping of the Cterminal third of PIF-1B (residues 683 -1041) for domains that interact with the full length L63B1 isoform, again using the two-hybrid assay. The L63 interaction domain in PIF-1B includes residues within the 788-815 region (see sequence in green in Fig. 3 ). This transition in binding capacity correlates with an acute increase in the frequency of cysteine residues within the 788-868 region (see sequence in red in Fig. 3 ), from 4^1% in the 683 -787 region to 25% in the adjacent 788-815 segment (Fig. 5A) . Fig. 5B shows that the primary structure of PIF-2 is divisible into an N-proximal region [MCSP (CCXZ) 16 ] and a C-proximal region [(CCXZ) 10 CGGSKCK] that are linked by a CCK tripeptide (see the red PIF-2 sequence in Fig. 3 ). Note that Z is proline in all 10 of the tetrapeptide repeats in the C-proximal region, and in 13 of the 16 repeats in the Nproximal region. The low resolution deletion mapping of PIF-2 for domains that interact with L63B1 ( Fig. 5B) indicates that the (CCXZ) 2 -15 part of the N-proximal region (the sequence in green in Fig. 3) is sufficient for the L63B1 interaction (residues 9 -64), although fractions of this tandem array, or presumably of the C-proximal array, may well suffice.
Curiously, the amino acid sequences of the PIF-1B and PIF-2 domains that interact with a common L63 domain exhibit little sequence similarity. While this apparent anomaly may result from inadequate resolution in mapping the interaction domain(s) in L63, it could also result from inadequate sequence comparisons. For example, Fig. 5C shows that despite an apparent irregular spacing of cysteine residues within the PIF-1B domain, each of these residues can be matched with a member of the set of regularly spaced cysteine residues in the PIF-2 domain.
2.4. Developmental profiles of PIF-1 mRNA and protein abundances indicate that PIF-1 expression is controlled at both transcriptional and translational levels Fig. 6A shows the temporal profiles for PIF-1 transcripts that were detected by Northern analyses using a 32 P-labeled riboprobe complementary to that portion of the PIF-1 mRNA encoding PIF-1B residues 683 -1041 plus the noncoding 3 0 terminus (see the hatched region in Fig. 2 ). The , 6.5 kb RNA first detected at 8-12 h of embryonic development corresponds to this dicistronic PIF-1 mRNA, which contains 6356 nucleotides plus a poly A tail. Its high abundance at the end of embryogenesis is followed by two waves of abundance that mark the first two larval instars (L1, L2) -waves that are followed by a period of high abundance during the third larval instar (L3). The abundance then drops to low levels during the 12 h prepupal period (PP). Dropping even lower during the 1st day of the pupal (P) period, a high abundance is regained during the last 2 days before the adult flies emerge, both adult sexes exhibiting high levels of the PIF-1 mRNA (Fig. 6A) . Confirmation that the 6.5 kb mRNA detected at these developmental stages by Northern analysis is indeed the dicistronic PIF-1 mRNA shown in Fig. 2 , was obtained by RT-PCR and sequence analysis of cDNAs in embryonic, late-larval and mid-pupal libraries (data not shown). This 6.5 kb PIF-1 mRNA is not, however, the first RNA detected by the PIF-1 riboprobe. Rather, a 5.6 kb RNA is detected in the 4 -8 h embryos and continues in high abundance to the end of embryogenesis. Disappearing during L1, it -or an RNA of similar mobility-is again weakly detected by the PIF-1 riboprobe during the last 16 h of L3. Although the sequence of the 5.6 kb RNA has not been determined, its size and strong hybridization with the PIF-1 riboprobe suggest that it is a splice variant of the 6.5 kb PIF-1 mRNA that contains all, or most, of the sequences complementary to the PIF-1 riboprobe, but lacks sequences provided by one or more of the PIF-1 exons ( Fig. 2A) .
The dicistronic nature of the PIF-1 mRNA raises the question of whether both coding sequences are translated from the 6.5 kb mRNA, and if so, how that translation is regulated during development. We addressed this question by carrying out developmental Western blots using protein extracts from whole animals sacrificed at 12 h intervals and rabbit polyclonal antibodies raised against the PIF-1A and PIF-1B proteins (Fig. 6B) . While little or no PIF-1 protein was detected during the first half (12 h) of embryogenesis, a relatively high level of PIF-1A protein was observed during the second half, accompanied by a low level of PIF-1B protein. Both proteins exhibit an abundance maximum immediately following embryogenesis in early L1, after which the PIF-1A abundance decreases rapidly to levels that are barely detectable in L2 and L3. In contrast, PIF-1B abundance remains high during all larval stages, in coordination with the 6.5 kb mRNA levels (Figs. 6A,B) . These observations suggest that there may be a division of labor in the translation of the PIF-1 mRNAs such that the PIF-1B protein is preferentially translated from the 6.5 kb mRNA, and the PIF-1A protein from a PIF-1 mRNA variant. This proposition is supported by the reappearance of the PIF-1A protein at pupariation (PP) (along with two satellite bands, one of which may be the same as that first detected during embryogenesis), concurrent with an abrupt decrease in the abundance of the 6.5 kb mRNA (Fig. 6A) .
The corresponding abundance of the PIF-1B protein (Fig.  6B) , could be the result of an increased protein stability during that period. The subsequent decrease in abundance of PIF-1B and the three PIF-1A isoforms during the first 48 h of the pupal period is reversed by an increase in their abundance during the final 36 h. Curiously, during this same period a second protein recognized by the PIF-1B antibody appears, and it is this protein that is the majority protein in adults.
The domain in PIF-1B that is required for interaction with L63 in yeast binds L63 in vitro
We used the L63 protein found in Drosophila Schneider S2 cultured cells to test whether the PIF-1B/L63 interaction observed in yeast (Fig. 5A ) occurs in vitro. This choice derived from our finding that these S2 cells contain L63 in high abundance (Fig. 7A) . Two bands are detected in extracts of these cells by Western analysis with an L63-specific monoclonal antibody called E1 -44, which is directed against a C-terminal epitope (Stowers et al., 2000) . The protein forming the upper Fig. 5 . Domains of PIF-1B and PIF-2 interacting with L63. Mapping of the domains of PIF-1B (A) and PIF-2 (B) interacting with L63 using the two-hybrid system. PIF-1B (amino acids 683-1041 and C-terminal deletions) and PIF-2 (amino acids 1-118 and C-terminal deletions) GAL4 AD fusions are diagrammed, together with their ability (þ) or inability (2) to interact with L63B1wt. The number of (þ ) is relative to the growth rate on the selective media (Section 4). In (A), The frequency of cysteine residues along the PIF-1B amino acid sequence is represented (green), the white box within PIF-1B corresponding to the cys-rich domain (residues 788-862). (C) Alignment of the domains of PIF-1B and PIF-2 that interact with L63 (residues 788-815 and 9-64, respectively). Conserved cysteine residues are shown in red.
band is a phosphorylated derivative of that forming the lower band, as shown by the transformation of the two bands to a single lower band upon treatment with alkaline phosphatase (Fig. 7A ).
To test for the PIF-1B/L63 protein interaction in vitro, we used sepharose beads carrying a covalently bound polypeptide corresponding to PIF-1B residues 756 -845, which are sufficient for the PIF-1B/L63 interaction in yeast Northern blotting was performed as described (Stowers et al., 2000) , using a riboprobe overlapping the two-hybrid clone (ribonucleotides 4918-6356 of PIF-1B, see hatched region in Fig. 2 ). Approximative mRNA sizes are given on the right in kilobases (kb). (B) PIF-1 developmental Western blot. Protein extracts from staged animals were blotted with PIF-1A (upper panel) or PIF-1B (lower panel) polyclonal antibodies. kDa, kilodalton. Stages in A and B are given in hours after egg laying. E, embryo; L1, first instar larva; L2, second instar larva; L3, third instar larva; PP, prepupa; P, pupa; A, adult. Pull-down assay of L63 using immobilized PIF-1B peptides. S2 lysates were incubated with sepharose beads (lane 2) or purified peptides corresponding to amino acids 1-224 and 756 -845 of PIF-1B (lanes 3 and 4, respectively) immobilized on sepharose beads. Washed beads were equilibrated in the kinase buffer and subjected to a kinase assay in the presence of [g-32 P]ATP, using myelin basic protein (MBP) as a substrate. The reactions were separated by SDS-PAGE followed by autoradiography (panel b). Lane 1 is a control for the kinase assay, where the reaction mix was incubated with no beads. As a loading control, MBP was stained with Coomassie brilliant blue (panel g). Recovery of L63 was confirmed by Western blot using the E1-44 monoclonal antibody (panel a). Relative kinase activity is a mean of three independent experiments, and was determined by phosphorimager quantification of MBP phosphorylation. (C) In vivo coimmunoprecipitation of L63 and PIF-1B proteins. Lysates (100 mg of protein) from 0 to 2 h embryos (E) and adult flies (A) were incubated with protein G beads (2) or protein G/anti-L63 E1-44 beads (E1-44), as described in Section 4. Half of the immunoprecipitates (IP) were separated by SDS-PAGE (lanes 3-6), in parallel to input lysates (2.3 mg; lanes 1 and 2), and recovery of PIF-1B was analyzed by Western blot using the PIF-1B polyclonal antibody. (Fig. 5A ). Lane 4 of Fig. 7B(a) shows that these beads specifically bound L63 contained in the S2 cell lysates, compared to control beads carrying a polypeptide corresponding to PIF-1B residues 1 -224 (lane 3), or sepharose beads alone (lane 2).
L63 is an active kinase
Prior evidence that the L63 protein is a kinase is of two kinds: (i) it contains a CDK-like domain (Fig. 1) ; and (ii) its inactivation by site-directed mutagenesis of residues known to be critical for CDK activity (Stowers et al., 2000) . Here we provide direct evidence that the L63 protein bound to PIF-1B residues 786 -845 ( Fig. 7B(a) , lane 4) can phosphorylate myelin basic protein (MBP), used as an in vitro substrate. Thus, Fig. 7B(b) shows that the protein kinase activity associated with L63 (lane 4) is 7.8 times and 4.2 times higher than that for the sepharose bead control (lane 2) and the sepharose beads carrying the 1-224 residue PIF-1B polypeptide (lane 3), respectively -given that the MBP substrate levels are the same (Fig. 7B(g), lanes 1-4) . No kinase activity was detected when MBP was incubated alone in those assays (Fig. 7B(b) , lane 1). When histone H1, an efficient substrate for PSTAIRE-containing CDKs, was used instead of MBP, no kinase activity specific for L63 was detected (not shown).
Coimmunoprecipitation assays indicate that L63 and PIF-1B interact in vivo
Early embryos (0 -2 h) and young adults were chosen as sources for protein extracts containing, respectively, little or no PIF-1B protein, and high levels of this protein (see Fig.  6B ). Both extracts, in contrast, contain relatively high levels of L63, which we found to be readily precipitated by either the A2 -6 or E1-44 monoclonal antibodies that are specific for the N-and C-terminal L63 residues, respectively (Stowers et al., 2000) . Coimmunoprecipitation assays of these extracts were then carried out with the A2 -6 or E1 -44 antibodies, and the amount of the PIF-1B protein in the resulting immunocomplexes determined with the PIF-1B polyclonal antibody. Fig. 7C shows that when the Cterminal specific E1 -44 L63 antibody was used for the immunoprecipitation, a strong band of PIF-1B was detected with the adult extract (Fig. 7C , compare lane 6 to the no antibody control in lane 5). A weaker PIF-1B signal was detected with the 0 -2 h embryonic extract (lane 4), in accordance with its lower abundance in the extract (lane 1). The simplest interpretation of this result is that L63 and PIF-1B interact in vivo. No signal was detected after immunobloting with the PIF-1A antibody, or with the secondary antibody alone (not shown), providing further evidence that the detected signal is specific for PIF-1B. The detection of a weak PIF-1B signal with extracts from 0-2 h embryos (Fig. 7C, lane 1) is however curious given that PIF-1B was not detected in the 0-12 h embryo extract shown in 1 and 2 of Fig. 7C ), it may be of maternal origin, as opposed to the slower migrating embryonic PIF-1B detected only after 12 h of embryogenesis (Fig. 6B) . Interestingly, when the A2 -6 antibody was used for the immunoprecipitation of L63 in place of the E1 -44 antibody, no evidence for the coprecipitation of PIF-1B was obtained (results not shown). Although this is a negative result, it is consistent with the following interpretation. The A2 -6 antibody is directed against N-terminal L63 sequences that include the PIF-1B interacting domain (residues 54-89; Fig. 4A ). Hence, it would be expected to disrupt the L63/PIF-1B interaction. Alternatively, the L63/PIF-1B complex could mask the L63 epitope recognized by the A2 -6 antibody. Taken together, the results presented here indicate that L63 and PIF-1B interact in vivo.
Discussion
The Drosophila L63 isoforms belong to a family of CDK-like proteins characterized by relatively long Nterminal and short C-terminal extensions from their kinase domains (Fig. 1) , that includes mammalian PFTAIRE, PCTAIRE and PITSLRE proteins (see Section 1 and Table  1 ). A striking feature of this family is that no cyclin or cyclin-like partner has been identified for any member. The possibility of a cyclin-based activation of L63 was, however, raised by Stowers et al. (2000) . Using their technique of rescuing L63 null mutants with wild-type or mutant L63 transgenes, they found that the G243A mutation in L63 eliminated the wild-type rescue activity. This is the result expected for a cyclin-activated kinase because the conserved G243 glycine in L63 is the sequence equivalent of the G43 glycine in HuCDK2, which is thought to be essential for the HuCDK2/CYCA interaction because it is the only amino acid that will allow the two residues directly adjacent to it to form hydrogen bonds with the cyclin in the HuCDK2/CYCA cocrystal structure (Jeffrey et al., 1995) . Similarly, the partial inactivation of the rescue activity by the L63 I249L mutation (Stowers et al., 2000) is consistent with cyclin activation because I249 is the sequence equivalent of I49 in the PSTAIRE a-helix of HuCDK2, which fits tightly into the hydrophobic pocket of the cyclin in the HuCDK2/CYCA structure (Jeffrey et al., 1995) .
Despite such suggestions of a cyclin-like activation of L63, no cyclin or cyclin-like partner for L63 has been identified, although we have made extensive attempts to do so. PIF-1B and PIF-2 were the only proteins found to interact with the full-length L63B1 isoform in our extensive two hybrid screens. We also used the two-hybrid assay to test whether Drosophila cyclins A, B, C, D, and E interact with either the full-length L63B1, or with its kinase domain alone, with negative results. Furthermore, L63 is unlikely to be a cell-cycle regulator. Thus, we found that the L63 proteins are cytoplasmic in the rapidly dividing S2 cell populations (not shown), in keeping with similar observations in larval salivary and ring glands by Stowers et al. (2000) . Furthermore, these workers observed no effect of L63 null mutations on: (i) the fraction of cells undergoing mitosis in larval brains at pupariation; (ii) the degree of polytenization in larval salivary gland chromosomes; or (iii) on cell division in the developing eye. Finally, neither of two authentic Drosophila cell-cycle dependent kinases (CDK1 and CDK2) were capable of rescuing L63 null mutants (Stowers et al., 2000) .
These observations favor a cyclin-independent mechanism for the activation of L63. Evidence for such an activation mechanism has recently been obtained for another member of the above family, the human PCTAIRE1 kinase. Thus, Graeser et al. (2002) found that the PCTAIRE1 kinase activity was altered by phosphorylation of two of the four serine residues in its 161-residue Nterminal extension that are protein kinase A (PKA) substrates. These residues (S119, S153) are the closest to the kinase domain, which occupies residues 162 -446 in this 497-residue protein. Thus, phosphorylation of S119 generated a binding site for the 14-3-3 isoforms previously identified as PCTAIRE1 interacting proteins in a yeast twohybrid screen (Le Bouffant et al., 1998; Sladeczek et al., 1997) , whereas phosphorylation of S153 inhibited PCTAIRE-1 kinase activity. Of most interest, however, is their finding that mutation of this S153 to alanine (S153A) resulted in an activated kinase. Furthermore, gel-filtration estimates of the size of the active PCTAIRE1 in brain extracts were consistent with a naked PCTAIRE1 monomer lacking a cyclin or cyclin-like partner (Graeser et al., 2002) . These results indicate that the PCTAIRE1 N-terminal sequences control the activation of this kinases and may indeed provide the activation functions that the cyclins provide for the model CDKs.
The finding of a cyclin-independent activation mechanism for the human PCTAIRE-1 raises the question of whether the activation of other members of the family, particularly the L63 kinase, also result from such mechanisms. Indeed, L63 and PCTAIRE share other common characteristics, such as their cytoplasmic localization (Besset et al., 1999; Charrasse et al., 1999) , the presence of protein interaction domains within their long N-terminal extensions (Hirose et al., 2000; Le Bouffant et al., 1998) , the preference for MBP over histone H1 as an acceptor substrate (Besset et al., 1999; Charrasse et al., 1999) , and their association with cellular differentiation rather than proliferation (Besset et al., 1999; Graeser et al., 2002; Hirose et al., 1997) . There are, however, several reasons why the activation of L63 would differ from that described for PCTAIRE-1. First, the sequence similarity between L63B1 and the human PCTAIRE-1 does not include their Nterminal extensions, which therefore inhibits assignment of the PCTAIRE-1 activation mechanism to L63. Second, Graeser et al. (2002) found that a PCTAIRE-1 construct lacking all 162 residues of its N-terminal extension was catalytically inactive. This contrasts with the finding of Stowers et al. (2000) that such an N-terminal truncation of L63 yielded a protein with significant activity in their assay for the rescue of L63 null mutants by wild-type or mutant transgenes. It therefore appears that an L63 protein that lacks its N-terminal extension is functional, although this extension might modify that function. Indeed, we think that such a modification could provide a mechanism by which the PIF-1B and/or PIF-2 proteins control the L63 kinase activity.
The identification of PIF-1B and PIF-2 by the two-hybrid assay is a highly specific result not simply because only two proteins were identified from two large cDNA libraries representing different stages of Drosophila development, but most remarkably because these quite different proteins (Fig. 3) bind to the same L63 sequence (Fig. 4) . Furthermore, this L63 binding site is remarkable both for its position in the L63 N-terminal extension, and for its sequence. It is located downstream of the N-terminal sequences that distinguish the L63A and B isoforms, and upstream of the sequence that is uniquely absent from the A2 and B2 isoforms (Fig. 1) . Hence it is present in the Nterminal extensions of all five L63 isoforms, consistent with the thesis that these isoforms are functionally equivalent (see Section 1). Its sequence is remarkable because it contains a polyhistidine tract that is followed by a glycinerich motif, (i.e. HHHHHHHHHxxGHGG), and because the same sequence is found at the amino terminus of SNF1 -a yeast serine/threonine protein kinase ( Fig. 4B ; Hardie et al., 1998) which also interacts with PIF-1B and PIF-2 in our two-hybrid assay. SNF1 plays an essential role in the glucose-starvation signaling pathway of yeast, but the function of the above sequence is not known. No yeast homologs of PIF-1B and PIF-2 were found in the database, and overexpression of PIF-1B and PIF-2 in yeast did not significantly affect SNF1 function (M. Carlson, personal communication) .
This specificity of the PIF/L63 interaction, when coupled with the finding that L63 minus its N-terminal extension is active, prompts the proposition that the N-terminal extension inhibits the L63 kinase, and that the binding of a PIF protein counters that inhibition, thereby activating L63. Given the sequence similarity between the L63 kinase domain and the CDKs, we assume that this domain has the same basic structure as that conserved among the serine/-threonine and tyrosine kinases-namely, a structure dominated by two subdomains called the N and C lobes. Some of these kinases are like L63 in having a long N-terminal extension that precedes the N lobe, and in some of these, such as the Src family of tyrosine kinases, that tail folds back to inactivate the kinase function (reviewed by Huse and Kuriyan, 2002) , much as we suppose to be the case for L63. While explicit tests of the proposition that PIF proteins activate the L63 kinase made inactive by its own N-terminal extension have yet to be carried out, certain of our results favor it. Thus, we show that L63 bound to PIF-1B residues 786 -845 exhibits highly significant levels of kinase activity (Fig. 7B) . This result is to be contrasted with our finding that immunoprecipitates of L63 obtained with the A2 -6 L63 monoclonal antibody specific for the N-terminal His-rich domain, tested negative for PIF-1B (Section 2.7) and exhibited a lower kinase activity (results not shown).
A second model for PIF function -not necessarily in conflict with the first -derives from the observation of Stowers et al. (2000) that L63 mutants exhibit defects in leg morphogenesis, often resulting in the bent leg phenotype. These observations led to their proposal that L63 proteins are required for a remodeling of the cytoskeleton which leads to changes in cell shape that in turn drives leg elongation -a control that they suppose derives from the phosphorylation by the L63 kinase of critical cytoskeletal proteins. One possibility is that the PIF-1B protein acts as a recruiting factor for the L63 proteins, directing them to the cytoskeleton where they catalyze that phosphorylation. In this connection, we note sequence similarities between the cysteine-rich regions of PIF-1B (Fig. 3) and the LIM/RINGlike domains of the dynactins that are involved in the interaction with cytoskeletal components (Garces et al., 1999; Holleran et al., 1998; Karki et al., 2000) .
Refining our preliminary models for the postulated PIF functions noted above to produce a solid working model for these functions requires additional work, such as: (i) determining whether the PIF proteins colocalize with L63 at specific anatomical sites during development; (ii) mutational and RNAi analysis of the PIF genes; and (iii) biochemical analysis of the effect of PIF proteins on L63 kinase activity. Finally, we note that variants of the PIF-1 mRNA have recently been identified, which suggests that the 18 kb PIF-1 transcription unit is more complex than that represented in Fig. 2 (see legend to Fig. 2 ). The PIF-1 gene therefore appears to be more complex and interesting than we first imagined.
Experimental procedures
Plasmids (yeast)
pDB-L63wt was constructed by inserting a 1563 bp NaeI-BamHI fragment, corresponding to amino acids 19-522 of the L63B1 cDNA (Stowers et al., 2000) , into the NcoI (blunt)-BamHI sites of pAS2 (Clontech), generating a GAL4 DNA binding domain (DB)-L63 fusion. The deleted versions of L63 (Fig. 4) were derived from pDB-L63wt, by using internal restriction sites. pAD-PIF-1B 683 -1041 and pAD-PIF-2 correspond to the two-hybrid clones. pAD-PIF-1B 683 -1041 contains a 1400 bp cDNA fragment inserted into the EcoRI-XhoI sites of pAD-GAL4 (Stratagene), and corresponds to amino acids 683 -1041 of the full-length PIF-1B. pAD-PIF-2 contains a 864 bp cDNA fragment inserted into the XhoI site of pACT (Clontech). The deleted versions of PIF-1 and PIF-2 (Fig. 5) were generated from pAD-PIF-1B 683 -1041 and pAD-PIF-2, respectively, using internal restriction sites. All constructs were confirmed by sequencing.
Yeast two-hybrid screen
The yeast strain PJ69-4A (James et al., 1996) was cotransformed with pDB-L63wt (Trp) and Drosophila cDNA libraries fused to the activation domain (AD) of GAL4 (Leu), as described (Gietz and Schiestl, 1995) . The Drosophila libraries used were a late third instar cDNA library (a kind gift from Steve Elledge, unpublished) for the isolation of PIF-2, and a 34 -54 h pupae library (Pat Hurban and David S. Hogness, unpublished) for PIF-1B. Transformants were selected on Ade þ , and checked for His þ (in the presence of 25 mM 3-amino-1, 2, 4-triazole) and LacZ þ . Positivity was confirmed by retransforming PJ69-4A with AD plasmids isolated from yeast, either alone or together with pDB-L63wt. Specificity of the interaction with L63 was assessed against other Drosophila CDKs (CDK1, CDK2, CDK5), unrelated Drosophila proteins (EcR, Usp, DHR3), or yeast SNF1 (ySNF1), in fusion with the GAL4 DNA binding domain (data not shown; see text). Mapping of the interaction domains (Figs. 4 and 5) was performed in PJ69-4A.
Cloning of full length PIF-1 cDNA
Cloning of the full-length PIF-1 cDNA was performed by screening the 0-24 h embryonic LD library from the Berkeley Drosophila Genome Project, as described in the Stratagene instruction manual for lambda ZAP II library. A unique 6356 bp PIF-1 cDNA was isolated three times, and its complete sequence was generated from both strands.
Northern blot
Total RNA purification and Northern blotting were performed as described previously (Stowers et al., 2000) . The PIF-1 riboprobe was made from plasmid pAD-PIF-1B 683-1041 (nucleotides 4918 -6356 of PIF-1B) using the T7 RNA polymerase promoter, after linearization by EcoRI. A DNA probe from the rp49 gene (O'Connell and Rosbash, 1984) was used as a loading control and showed that each lane was equal to each other, with the exception of lanes E 0 -2 h, E 4 -8 h, and L2 48 -60 h which were approximately 2-fold underloaded (data not shown).
Western blot
Western blotting was carried out as described in PIERCE instruction manual for ECL Western blotting, and developed using Supersignal West Pico Chemoluminescence Substrate (PIERCE). Anti-L63 E1 -44 and A2 -6 antibodies were used 1:150, affinity purified polyclonal anti-PIF-1A and anti-PIF-1B antibodies were used 1:500, and secondary antibodies (goat anti-mouse, BIORAD; goat anti-rabbit, Vector Laboratories) were used 1:8000.
Antibodies
The monoclonal antibodies directed against L63 have been described (Stowers et al., 2000) . Their corresponding epitopes are as follows: A2 -6 (amino acids 54 -89), E1 -44 (amino acids 484-522), and E3-53 (amino acids 484 -522). Polyclonal antibodies directed against PIF-1A (amino acids 446 -695), and PIF-1B (amino acids 756-845) were generated in New Zealand rabbits, essentially as described (Harlow and Lane, 1988) , and immunoaffinity purified from the third bleed against the corresponding purified peptides immobilized on sepharose 4B beads (see below). Antibodies were eluted from the affinity column with 100 mM glycineHCl (pH 2.5) and the pH neutralized with three volumes of 100 mM Tris -HCl (pH 8.0). Purified antibodies were concentrated (Centriplus 100, AMICON) and stored at 2 208C in 50% glycerol. Specificity of the polyclonal antibodies was verified by Western blot on in vitro translated PIF-1A and PIF-1B products (data not shown).
Recombinant proteins
Peptides corresponding to amino acids 446 -695 of PIF-1A, amino acids 1 -224 of PIF-1B, and amino acids 756 -845 of PIF-1B were produced in BL21(DE3) bacteria (Stratagene) as 6xhis-fusions (pET system, NOVAGEN), and affinity purified on a TALON metal affinity resin (CLONTECH) under denaturing conditions (6 M Guanidium HCL), following the manufacturer's recommendations. For antibody production, peptides were further purified by SDS-PAGE and electroelution before injecting into rabbits. For antibody immunoaffinity purification and pull-down assays, TALON-purified peptides were immobilized on sepharose 4B beads, by coupling to cyanogen bromide (CnBr)-activated sepharose 4B (SIGMA) following the manufacturer's recommendations. CnBr-activated sepharose 4B beads were treated in parallel with buffer only, as a sepharose bead control for pull-downs (Fig. 7) .
Cell and animal protein lysates
S2 cells were grown in Schneider's Drosophila medium (SIGMA) supplemented with 10% Fetal Bovine Serum (Gibco BRL) and 2% pennicillin-streptomycin (SIGMA). S2 cells were washed in PBS, and lysed in Xiong buffer (50 mM Tris -HCl pH 7.4, 150 mM NaCl, 0.5% NP40, 50 mM NaF, supplemented with 1 mM Na 3 Vo 4 , 1 mM DTT, 1 mM PMSF, Boehringer protease inhibitor cocktail) for 1 h at 48C. Protein concentration was determined using BIORAD Protein Assay (Bradford). For the developmental Western, animals (w1118 fly stocks) from the indicated stages were frozen in liquid nitrogen, tissues were disrupted with a pestle and lysed in Laemmli buffer (50 mM Tris -HCl pH 6.8, 2% SDS, 5% 2-b-mercaptoethanol, 10% glycerol, 0.005% bromophenol blue) by boiling for 10 min. Relative protein amounts were determined by Ponceau stain of diluted dots (2-fold dilution scale) on nitrocellulose membrane. For in vivo immunoprecipitations, 0 -2 h embryos and adult (male and female) animals (w1118 fly stocks) were frozen in liquid nitrogen, tissues were disrupted with a pestle and lysed in Xiong buffer for 1 h at 48C. Protein concentration was determined by Bradford.
